E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury

Experimental Cell Research

Volumn 251, Issue 2, 1999, Pages 414-423

  Cook, James L ^a   Routes, Barbara A ^b   Walker, Thomas A ^b   Colvin, Kelley L ^b   Routes, John M ^b,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Adenovirus; Apoptosis; Beauvericin; Cytolytic lymphocyte; E1A; NIH 3T3; Oncogene

Indexed keywords

BEAUVERICIN; DNA; ETOPOSIDE; GRAMICIDIN; ONCOPROTEIN;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC LYMPHOCYTE; HAMSTER; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RAT; SARCOMA CELL; SENSITIZATION;

ADENOVIRIDAE; ANIMALIA; CRICETINAE; MAMMALIA;

EID: 0033568587     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4597     Document Type: Article

References (60)

1. Adami G. R., Babiss L. E. The efficiency of adenovirus transformation of rodent cells is inversely related to the rate of viral E1A gene expression. J. Virol. 64:1990;3427-3436.
2. Arase H., Arase N., Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1995;1235-1238.
3. Barbeau D., Charbonneau R., Whalen S. G., Bayley S. T., Branton P. E. Functional interactions within adenovirus E1A protein complexes. Oncogene. 9:1994;359-373.
4. Bennett M. R., Evan G. I., Schwartz S. M. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ. Res. 77:1995;266-273.
5. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects. Annu. Rev. Immunol. 12:1994;735-773.
6. Chiou S. K., Rao L., White E. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14:1994;2556-2563.
7. Chiou S. K., White E. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J. Virol. 71:1997;3515-3525.
8. Cook J., Iklé D., Routes B. Natural killer cell ontogeny in the athymic rat: Relationship between functional maturation and acquired resistance to E1A oncogene-expressing cells. J. Immunol. 155:1995;5512-5518.
9. Cook J., Krantz C., Routes B. Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor rejection. Proc. Natl. Acad. Sci. USA. 93:1996;13985-13990.
10. Cook J. L., Hauser J., Patch C. T., Lewis A. M. Jr., Levine A. S. Adenovirus 2 early gene expression promotes susceptibility to effector cell lysis of hybrids formed between hamster cells transformed by adenovirus 2 and simian virus 40. Proc. Natl. Acad. Sci. USA. 80:1983;5995-5999.
11. Cook J. L., Lewis A. M. Jr. Host response to adenovirus 2 transformed hamster embryo cells. Cancer Res. 39:1979;1455-1461.
12. Cook J. L., Lewis A. M. Jr. Differential NK cell and macrophage killing of hamster cells infected with nononcogenic or oncogenic adenovirus. Science. 224:1984;612-615.
13. Cook J. L., Lewis A. M. Jr. Immunological surveillance against DNA virus-transformed cells: Correlations between natural killer cell cytolytic competence and tumor susceptibility of athymic rodents. J. Virol. 61:1987;2155-2161.
14. Cook J. L., Lewis A. M. Jr., Klimkait T., Knust B., Doerfler W., Walker T. A. In vivo evolution of adenovirus 2-transformed cell virulence associated with altered E1A gene function. Virology. 163:1988;374-390.
15. Cook J. L., May D. L., Lewis A. M. Jr., Walker T. A. Adenovirus E1A gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells. J. Virol. 61:1987;3510-3520.
16. Cook J. L., May D. L., Wilson B. A., Holskin B., Chen M.-J., Shalloway D., Walker T. A. Role of tumor necrosis factor-alpha in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages. J. Immunol. 142:1989;4527-4534.
17. Cook J. L., May D. L., Wilson B. A., Walker T. A. Differential induction of cytolytic susceptibility by E1A, myc, and ras oncogenes in immortalized cells. J. Virol. 63:1989;3408-3415.
18. Cook J. L., Potter T. A., Bellgrau D., Routes B. A. E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes. Oncogene. 13:1996;833-842.
19. Cook J. L., Wilson B. A., Wolf L. A., Walker T. A. E1A oncogene expression level in sarcoma cells: An independent determinant of cytolytic susceptibility and tumor rejection. Oncogene. 8:1993;625-635.
20. Curnow S. J., Glennie M. J., Stevenson G. T. The role of apoptosis in antibody-dependent cellular cytotoxicity. Cancer Immunol. Immunother. 36:1993;149-155.
21. Debbas M., White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:1993;546-554.
22. Duke R., Cohen J. Morphological and biochemical assays of apoptosis. Curr. Prot. Immunol. 3:1992;3.17.11-13.17.16.
23. Duvall E., Wyllie A. H. Death and the cell. Immunol. Today. 7:1986;115-119.
24. Franza B. R., Maruyama K., Garrels J. I., Ruley H. E. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell. 44:1986;409-418.
25. Frisch S. M. Antioncogenic effect of adenovirus E1A in human tumor cells. Proc. Natl. Acad. Sci. USA. 88:1991;9077-9081.
26. Harlow E., Franza R. Jr., Schley C. Monoclonal antibodies specific for adenovirus early region 1A proteins: Extensive heterogeneity in early region 1A products. J. Virol. 55:1985;533-546.
27. Hitt M. M., Graham F. L. Adenovirus E1A under the control of heterologous promoters: Wide variation in E1A expression levels has little effect on virus replication. Virology. 179:1990;667-678.
28. Khar A., Pardhasaradhi B. V., Varalakshmi C., Ali A. M., Kumari A. L. Natural killer cell as the effector which mediates in vivo apoptosis in AK-5 tumor cells. Cell. Immunol. 177:1997;86-92.
29. Kirshenbaum L. A., Schneider M. D. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J. Biol. Chem. 270:1995;7791-7794.
30. Lin H. J., Eviner V., Prendergast G. C., White E. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol. Cell. Biol. 15:1995;4536-4544.
31. Liu C. C., Young L. H., Young J. D. Lymphocyte-mediated cytolysis and disease. N. Engl. J. Med. 335:1996;1651-1659.
32. Loike J. D., Horwitz S. B. Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells. Biochemistry. 15:1976;5443-5448.
33. Lowe S. W., Ruley H. E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:1993;535-545.
34. Lowe S. W., Ruley H. E., Jacks T., Housman D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
35. Marcellus R. C., Teodoro J. G., Wu T., Brough D. E., Ketner G., Shore G. C., Branton P. E. Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis. J. Virol. 70:1996;6207-6215.
36. Moran B., Zerler B. Interactions between cell growth-regulating domains in the products of the adenovirus E1A oncogene. Mol. Cell. Biol. 8:1988;1756-1764.
37. Moran E., Zerler B., Harrison T. M., Mathews M. B. Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes. Mol. Cell. Biol. 6:1986;3470-3480.
38. Mymryk J. S., Shire K., Bayley S. T. Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block. Oncogene. 9:1994;1187-1193.
39. Nakajima T., Morita K., Ohi N., Arai T., Nozaki N., Kikuchi A., Osaka F., Yamao F., Oda K. Degradation of topoisomerase II alpha during adenovirus E1A-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system. J. Biol. Chem. 271:1996;24842-24849.
40. Nakajima T., Ohi N., Arai T., Nozaki N., Kikuchi A., Oda K. Adenovirus E1A-induced apoptosis elicits a steep decrease in the topoisomerase II alpha level during the latent phase. Oncogene. 10:1995;651-662.
41. Ojcius D., Zychlinsky A., Zheng L., Young J.-E. Ionophore-induced apoptosis: Role of DNA fragmentation and calcium fluxes. Exp. Cell Res. 197:1991;43-49.
42. Querido E., Teodoro J. G., Branton P. E. Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. J. Virol. 71:1997;3526-3533.
43. Rao L., Debbas M., Sabbatini P., Hockenbery D., Korsmeyer S., White E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA. 89:1992;7742-7746.
44. Raska K. Jr., Gallimore P. H. An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology. 123:1982;8-18.
45. Routes J. M., Cook J. L. E1A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus infection of human cells. Virology. 210:1995;421-428.
46. Routes J. M., Li H., Bayley S. T., Ryan S., Klemm D. J. Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding. J. Immunol. 156:1996;1055-1061.
47. Sabbatini P., Lin J., Levine A. J., White E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9:1995;2184-2192.
48. Sakamuro D., Sabbatini P., White E., Prendergast G. C. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene. 15:1997;887-898.
49. Sawada Y., Fohring B., Shenk T. E., Raska K. Jr. Tumorigenicity of adenovirus-transformed cells: Region E1A of adenovirus 12 confers resistance to natural killer cells. Virology. 147:1985;413-421.
50. Sheil J. M., Gallimore P. H., Zimmer S. G., Sopori M. L. Susceptibility of adenovirus 2-transformed rat cell lines to natural killer (NK) cells: Direct correlation between NK resistance and in vivo tumorigenesis. J. Immunol. 132:1984;1578-1582.
51. Sutton V. R., Vaux D. L., Trapani J. A. Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes. J. Immunol. 158:1997;5783-5790.
52. Teodoro J. G., Shore G. C., Branton P. E. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene. 11:1995;467-474.
53. Velcich A., Ziff E. Adenovirus E1A proteins repress transcription from the SV40 early promoter. Virology. 40:1985;705-716.
54. Vujanovic N. L., Nagashima S., Herberman R. B., Whiteside T. L. Nonsecretory apoptotic killing by human NK cells. J. Immunol. 157:1996;1117-1126.
55. Walker T. A., Wilson B. A., Lewis A. M. Jr., Cook J. L. E1A oncogene induction of cytolytic susceptibility eliminates sarcoma cell tumorigenicity. Proc. Natl. Acad. Sci. USA. 88:1991;6491-6495.
56. Wang H.-G. H., Moran E., Yaciuk P. E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity. J. Virol. 69:1995;7917-7924.
57. Wang H. G., Rikitake Y., Carter M. C., Yaciuk P., Abraham S. E., Zerler B., Moran E. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67:1993;476-488.
58. White E., Sabbatini P., Debbas M., Wold W. S., Kusher D. I., Gooding L. R. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol. 12:1992;2570-2580.
59. Zajchowski D. A., Jalinot P., Kedinger C. EIA-mediated stimulation of the adenovirus EIII promoter involves an enhancer element within the nearby EIIa promoter. J. Virol. 62:1988;1762-1767.
60. Zychlinsky A., Zheng L. M., Liu C. C., Young J. D. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J. Immunol. 146:1991;393-400.